Advisor Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Advisor Group’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$0	Hold	85	–	–	﹤0.01%	5507
2019 Q3	$0	Hold	85	–	–	﹤0.01%	5491
2019 Q2	$0	Hold	85	–	–	﹤0.01%	5424
2019 Q1	$0	Buy	85 +54	+174%	+$142	﹤0.01%	5384
2018 Q4	$0	Buy	+31	New	+$101	﹤0.01%	5301
2018 Q3	–	Sell	-100	Closed	-$1K	–	5279
2018 Q2	$1K	Hold	100	–	–	﹤0.01%	4857
2018 Q1	$1K	Sell	100 -200	-67%	-$1.42K	﹤0.01%	4880
2017 Q4	$1K	Buy	+300	New	+$781	﹤0.01%	4885
2016 Q4	–	Sell	-625	Closed	-$5K	–	4679
2016 Q3	$5K	Buy	+625	New	+$4.21K	﹤0.01%	3923

Other funds holding SRNE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Advisor Group's SRNE Position: Q4 2019 in Review

Advisor Group held its Sorrento Therapeutics, Inc. (SRNE) position steady in Q4 2019 at 85 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5507.

Advisor Group first reported a position in SRNE in Q3 2016 and has held it in 9 quarters since. The position peaked at $5K in Q3 2016. 88 funds tracked by Wall St. Rank hold SRNE as of Q4 2019.

Advisor Group held 85 shares of Sorrento Therapeutics, Inc. worth $0 as of Q4 2019.
Advisor Group left its Sorrento Therapeutics, Inc. share count unchanged in Q4 2019.
Sorrento Therapeutics, Inc. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5507 holding.
Advisor Group first reported a position in Sorrento Therapeutics, Inc. in Q3 2016 and has held it in 9 quarters since.
Advisor Group's Sorrento Therapeutics, Inc. position peaked at $5K in Q3 2016.
88 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.